Business Standard

Beryl Drugs reports standalone net profit of Rs 0.34 crore in the June 2021 quarter

Image

Capital Market

Sales rise 70.74% to Rs 4.61 crore

Net profit of Beryl Drugs reported to Rs 0.34 crore in the quarter ended June 2021 as against net loss of Rs 0.20 crore during the previous quarter ended June 2020. Sales rose 70.74% to Rs 4.61 crore in the quarter ended June 2021 as against Rs 2.70 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales4.612.70 71 OPM %15.4011.48 -PBDT0.600.17 253 PBT0.30-0.18 LP NP0.34-0.20 LP

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 11 2021 | 5:06 PM IST

Explore News